Clinical trial on the efficacy of two interventions for discontinuing long term benzodiazepine use in primary care

Completed

• Conditions: Benzodiazepine use, reduction and withdrawal; Mental and Behavioural Disorders

• Registration Number: ISRCTN13024375
• Lead Sponsor: Health Service of the Balearic Islands (Servei de Salut de les Illes Balears [IB-salut]) (Spain)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07-27
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 495

Inclusion Criteria

1. Patients between 18 and 80 years
2. Recorded history of benzodiazepine consumption or an analogue at least 5 times a week for at least six months
3. A minimum of 6 months prescription of a benzodiazepine or similar

Exclusion Criteria

1. Patients with severe anxiety or depressive disorder, psychotic disorder, severe personality disorder, and/or psychiatric monitoring
2. Patients with cognitive impairment, terminal illness or serious medical conditions, illegal drug use or abuse alcohol, inability to sign informed consent
3. Institutionalised patients
4. Patients with exacerbation of symptoms of anxiety/depression whose doctor considers that the withdrawal of a benzodiazepine can be harmful at this time
5. Patients with limited capacity for understanding
6. Patients that have participated in a clinical research study during the last 3 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified